Every day, faculty and students in the College of Arts and Sciences undertake boundary-pushing research and creative activity. They investigate, innovate, and invent, asking the big questions and challenging conventional wisdom. They explore new perspectives and ways of doing things. And no matter what their fields are, they constantly strive to pursue new knowledge, find solutions to complex problems, and work for the greater good.
Seven faculty members within the College of Arts and Sciences have recently been awarded grants to explore racial equity issues within their fields of expertise.
The University cannot discharge any of its obligations to society unless it is first and foremost an institution dedicated to scholarship and scholarly objectives.
Herman B Wells, IU president, 1938–62
In his course on climate engineering, Ben Kravitz, assistant professor of Earth and Atmospheric Sciences, instructs students on the theory and methods of geoengineering, while also guiding their investigation into the broader implications of altering the climate.
Read Professor Kravitz's story
IU’s new Quantum Science and Engineering Center will study the rapidly developing field of quantum theory, particularly quantum entanglement, and “reflects the important contributions IU is making to this second quantum revolution.”
Learn about the center
Justin Kumar, professor of Biology, has spent his career researching flies for cell specification processes and outcomes; his use of photography and embrace of the arts in this research has made his work compelling for all audiences, from colleagues to students.
Read Professor Kumar's story
Indiana University is part of a consortium that just received a $37.6 million grant to develop and study DNA-encoded monoclonal antibodies as an additional way to fight SARS-CoV-2, the virus that causes COVID-19. Under the leadership of Jesper Pallesen, assistant professor of molecular and cellular biochemistry, IU’s team will be focused on the structural analysis of the DNA-encoded monoclonal antibodies, known as DMAbs, from the design phase all the way through to human clinical trial.
Read about the grant
